Motley Fool

Is Ocugen Stock Heading for a Crash?

Ocugen (NASDAQ: OCGN) shares took center stage earlier this year when the biotech joined the coronavirus vaccine race. The company partnered with India’s Bharat Biotech to co-develop and co-commercialize Bharat’s vaccine candidate — Covaxin — in the U.S. As a result, Ocugen shares soared as much as 763% in about six weeks. Now, some investors might be wondering if Ocugen will hang onto this positive momentum — or whether the stock is heading for a crash.

LEAVE A REPLY

Please enter your comment!
Please enter your name here